Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 30, 2012 03:15 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Financial calendar 2013

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} 5 February 2013 - Presentation of the fourth...
October 30, 2012 03:15 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Finansiell kalender 2013

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} 5.februar 2013 - Presentasjon av rapport for 4.kvartal...
October 30, 2012 03:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Third quarter 2012 report

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Oslo, Norway, 30 October 2012.Please find attached...
October 30, 2012 03:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Resultatrapport for 3.kvartal 2012

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Oslo, 30.oktober 2012Vedlagt er rapport for tredje...
September 24, 2012 09:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Results from the first clinical study of Amphinex to be presented at the ESMO 2012 Congress in Vienna

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Oslo, 24 September 2012 - PCI Biotech (PCIB) the...
September 24, 2012 09:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Results from the first clinical study of Amphinex to be presented at the ESMO 2012 Congress in Vienna

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Oslo, 24 September 2012 - PCI Biotech (PCIB) the...
September 18, 2012 11:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Updated investor presentation

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Lysaker, 18 September 2012 - Attached is an updated...
September 18, 2012 11:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Oppdatert investorpresentasjon

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Lysaker, 18.september 2012 - Vedlagt er en oppdatert...
September 10, 2012 02:57 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Presentation of the PCI technology with clinical examples at the EACMFS 2012 Congress in Dubrovnik

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Oslo, 10 September 2012 - PCI Biotech (PCIB) the...
August 21, 2012 02:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Gallegangskreft (kolangiokarsinom) valgt som neste indikasjon for PCI Biotech. Klinisk studie forventes igangsatt senest 1H 2013

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Oslo, 21.august 2012 - PCI Biotech (PCIB) melder i...